| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3449 |
| Trial ID | NCT05869279 |
| Disease | Chronic Lymphocytic Leukemia | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CARCIK-CD19 |
| Generation | 3rd |
| Phase | Phase1|Phase2 |
| Recruitment status | Not Recruiting |
| Title | Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia |
| Year | 2023 |
| Country | Italy |
| Company sponsor | Fondazione Matilde Tettamanti Menotti De Marchi Onlus |
| Other ID(s) | FT04CARCIK |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||